The effect of renin–angiotensin–aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design

Autor: García-Prieto, A.M., Verdalles, Ú., de José, A.P., Verde, E., Arroyo, D., Aragoncillo, I., Linares, T., Barbieri, D., Goicoechea, M.
Zdroj: In Hipertension y riesgo vascular July-September 2020 37(3):101-107
Databáze: ScienceDirect